FDA Inspection
Department of Defense - ArmyDepartment of Defense - Army – FDA Inspection, Aug 25, 2022
Record Details
This FDA Inspection record concerns Department of Defense - Army, with an inspection on August 25, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Department of Defense - Army
- Inspection Date
- August 25, 2022
- Product Type
- Biologics
View Company Profile
ID · f9202eee-a529-4d3b-b39c-ba776463c97a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1180205
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Department of Defense - Army
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 5, 2025 | NAI | Center for Biologics Evaluation and Research | |
| July 27, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 4, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 29, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 11, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department of Defense - Army
- FDA Inspection 1273021 - 2025-06-05
- FDA Inspection 1062017 - 2018-07-27
- FDA Inspection 953337 - 2015-12-04
- FDA Inspection 889163 - 2014-07-29
- FDA Inspection 776557 - 2012-04-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.